Northwestern University Clinical and Translational Science Institute (NUCATS)

西北大学临床与转化科学研究所 (NUCATS)

• 批准号: 10192856
• 负责人: Leena Sharma
• 金额: $ 110.86万
• 依托单位: NORTHWESTERN UNIVERSITY AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-08-12 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10192856
• 关键词: Academia; Appointment; Area; Clinical Sciences; Clinical Trials; Collaborations; Communities; Data; Dissemination and Implementation; Diverse Workforce; Doctor of Philosophy; Future; Genomics; Goals; Government; Grant; Individual; Industry; Institutes; Intervention; Laboratories; Mentors; Outcome Measure; Program Development; Publications; Records; Research; Research Personnel; Research Project Grants; Resource Development; Resources; Science; Testing; Training; Training and Education; Translational Research; Translations; United States Agency for Healthcare Research and Quality; United States National Institutes of Health; Universities; Vocational Guidance; base; career development; design; experience; falls; improved; innovation; peer coaching; programs; success; training opportunity

ABSTRACT: NUCATS began our KL2 program in 2008, along with numerous other programs to support K scholars across our hub. The 25 KL2 scholars who have participated in the program include 11 MDs, 8 MD/PhDs and 7 PhDs, whose research areas span laboratory-based translational discovery, outcome measures testing, genomic translation, clinical trials, and community-level interventions. As of fall 2018, 21 KL2 scholars have completed the program. The progress of the KL2 program at NU has been outstanding. The scholars' publication and grant records are exceptional. Seventy-five percent (15/21) of those who completed the program have received individual or independent NIH, DHHS, or AHRQ grant support, including 3 K08s, 1 K22, 5 K23s, 12 R01s, 2 R03s, 1 R18, 1 R21, and 1 R34 Furthermore, 85% of those who have completed the program received NIH support as a PI or a significant contributor, while 90% have received some form of NIH or non-NIH grant support. Subsequent to their appointment periods, our scholars have received a combined total of over $45 million in direct research grants as PIs. Approximately 704 publications (mean 34), as author or co-author, have been attributed to the 21 scholars who have completed the program, after they joined the KL2 program. These data document a strong and sustained impact of the NUCATS KL2 Career Development Program on the CTS community. Closely aligned with the overall goals of NUCATS, we will now build on our outstanding legacy and enhance our impact through three initiatives, by: refining our proven programs, which are based on robust mentoring teams and designed around the educational needs of individual scholars to provide them with optimal, personalized career development opportunities; providing career development resources including formal courses, peer mentoring and systematic career guidance to scholars across disparate areas of expertise; and integrating collaboration, training and resources for scholars, including opportunities for training in team science and community implementation and dissemination, for research experiences in academia, government and industry, and for interactions with other local CTSAs.

摘要：Nucats于2008年开始了我们的KL2计划，以及许多其他支持K的计划 我们枢纽的学者。参加该计划的25名KL2学者包括11个MD，8个 MD/PHD和7 PHD，其研究领域涵盖了基于实验室的翻译发现 测试测试，基因组翻译，临床试验和社区水平的干预措施。截至2018年秋季，21 KL2学者已经完成了该计划。 NU的KL2计划的进展非常出色。 学者的出版物和赠款记录很出色。七十五（15/21）的人 完成该计划已获得个人或独立的NIH，DHHS或AHRQ赠款支持，包括 3 K08，1 K22、5 K23，12 R01，2 R03，1 R18、1 R21和1 R34，其中85％ 完成了作为PI或重要贡献者的NIH支持的计划，而90％已收到 某种形式的NIH或非NIH赠款支持。在约会期间，我们的学者有 像PI一样，总共获得了超过4500万美元的直接研究补助金。大约704个出版物 （平均34）作为作者或合着者，已归因于完成该计划的21名学者 他们加入KL2计划后。这些数据记录了Nucats KL2的强大而持续的影响 CTS社区的职业发展计划。与核心的整体目标紧密相符，我们 现在将以我们杰出的遗产为基础，并通过三个举措来增强我们的影响： 经过验证的计划，这些计划基于强大的指导团队，并围绕着教育需求而设计 个别学者为他们提供最佳的个性化职业发展机会；提供 职业发展资源，包括正规课程，同伴指导和系统的职业指导 跨不同专业领域的学者；并整合学者的合作，培训和资源， 包括在团队科学和社区实施和传播中进行培训的机会 学术界，政府和工业的研究经验以及与其他本地CTSA的互动。